Angelalign Technology (6699) H1 2024 earnings summary

Executive summary

• Total case shipments rose 60.3% year-over-year to 152,900 for the six months ended June 30, 2024, with international shipments surging 512.8% and China shipments up 10.8%.

• Revenue increased 39.8% year-over-year to RMB861.5 million, driven by strong international growth (up 452.5%) and steady China performance (up 10.1%).

• Gross profit grew 47.1% to RMB537.9 million, with gross margin improving to 62.4% from 59.3% a year earlier.

• Adjusted net profit nearly doubled, up 95.8% year-over-year to RMB71.7 million; reported net profit fell 49.7% to RMB14.7 million due to non-operating items.

• No interim dividend was declared for the period.

Financial highlights

• China market revenue reached RMB633.3 million (+10.1%); international revenue RMB228.2 million (+452.5%), now 26.5% of total.

• Adjusted segment operating profit in China up 67.1% to RMB112.2 million; international segment loss widened to RMB114.2 million.

• Selling and marketing expenses rose 68.1% to RMB343.1 million; R&D expenses were RMB74.9 million (8.7% of revenue).

• Cash and term deposits increased to RMB2,810.3 million; bank borrowings at RMB324.0 million, gearing ratio 9.9%.

• Adjusted EBITDA rose to RMB109.1 million from RMB28.7 million year-over-year.

Outlook and guidance

• Plans to strengthen R&D, further digitalize operations, expand production capacity, and accelerate international market expansion.

• Management remains cautious due to macroeconomic uncertainties, including weak global recovery, geopolitical risks, and reduced consumer confidence.